Earnings report 📈 Stocks 🌍 United States

Flyte Aviation Reports Record Q3 2026 Aviation Revenue of $1.84 Million

Flyte Aviation achieved a 145% sequential revenue jump in Q3 2026, driven by a 129% surge in flight hours and fleet expansion, while moving to divest its medical device segment.

🕐 1 min read

1 assets impacted. Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: VJET ↑ 6/10 (70% confidence).

📊 Affected Assets (1)

VJET
Bullish 🤖 70%
📅 Short-term 🌍 US · Explicit

Record quarterly aviation revenue of $1,838,000 for the quarter ended September 30, 2026, a 145% sequential increase, with flight hours up 129% sequentially and more than 99% of flights flown on its own fleet. Three additional jets are expected to begin revenue service in Q4, and Canada, Bahamas and Caribbean approvals expand the addressable market. The nonbinding MedTech sale LOI is not assured, and the small absolute revenue base limits how much the market may reward the growth.

Catalysts
  • ▲ Record Q3 2026 aviation revenue of $1,838,000, up 145% sequentially
  • ▲ Three jets completing lessor inspections expected to join the fleet and fly revenue flights in the December quarter
Risk Factors
  • ▼ MedTech sale LOI signed November 1, 2026 is non-binding and may not lead to a definitive agreement
  • ▼ Revenue of $1.84 million is small in absolute terms and no profitability figures are given

🎯 Key Takeaways

  • Aviation revenue reached $1,838,000 for the quarter ended September 30, 2026, up 145% sequentially.
  • Total flight hours increased 129% sequentially, with over 99% of customer flights fulfilled by the company's own fleet.
  • Three additional jets are expected to enter revenue service during the December 2026 quarter following successful inspections.
  • The company reported a net loss of $15.1 million for Q3 2026, including a $13.3 million non-cash impairment charge related to MedTech assets.

📝 Executive Summary

Flyte Aviation, Inc. (VJET) posted record aviation revenue of $1,838,000 for the third quarter ended September 30, 2026, marking a 145% sequential increase. The company is transitioning to a pure-play private aviation model, having signed a non-binding letter of intent on November 1, 2026, to divest its legacy MedTech assets.

❓ FAQ

How fast did Flyte Aviation's revenue grow?

Quarterly aviation revenue reached $1,838,000 for the quarter ended September 30, 2026, a 145% sequential increase, with MedTech revenue of $280,000 up 4% sequentially and 24% year-over-year.

What is happening with the MedTech business?

Flyte signed a non-binding letter of intent on November 1, 2026 to sell Catheter Precision's VIVO, LockeT and associated assets, targeting completion by year-end 2026, but the sale is subject to due diligence, approvals and closing conditions and may not happen.